Metabolic disorders often overlap, making diabetes and endocrine connections a critical area of study. Hormonal imbalances involving the thyroid, adrenal, and pituitary glands influence glucose metabolism and insulin function. Conditions such as Cushing’s syndrome and hypothyroidism exacerbate insulin resistance, while polycystic ovary syndrome (PCOS) increases the risk of type 2 diabetes. Growth hormone and cortisol fluctuations also affect glycemic control, highlighting the need for a multidisciplinary approach in diagnosis and treatment. Advances in endocrinology have improved our understanding of these interactions, leading to targeted therapies that address both diabetes and underlying hormonal conditions. Recognizing these connections allows for more personalized and effective management strategies.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti